Cargando…
Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa
BACKGROUND: As HIV enters the human body, its main target is the CD4 cell which it turns into a factory that produces millions of other HIV particles. These HIV particles target new CD4 cells resulting in the progression of HIV infection to AIDS. A continuous depletion of CD4 cells results in opport...
Autores principales: | Shoko, Claris, Chikobvu, Delson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773025/ https://www.ncbi.nlm.nih.gov/pubmed/29343268 http://dx.doi.org/10.1186/s12976-017-0075-4 |
Ejemplares similares
-
Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa
por: Shoko, Claris, et al.
Publicado: (2018) -
A Markov Model to Estimate Mortality Due to HIV/AIDS Using Viral Load Levels-Based States and CD4 Cell Counts: A Principal Component Analysis Approach
por: Shoko, Claris, et al.
Publicado: (2018) -
Correction to: A Markov Model to Estimate Mortality Due to HIV/AIDS Using Viral Load Levels-Based States and CD4 Cell Counts: A Principal Component Analysis Approach
por: Shoko, Claris, et al.
Publicado: (2018) -
A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy
por: Shoko, Claris, et al.
Publicado: (2019) -
A Markov jump process approach to modeling blood donor status: Donor retention and attrition rates at a blood service center in Zimbabwe
por: Chikobvu, Delson, et al.
Publicado: (2022)